JLS Fund
New York City, New Yorkjls.fund
Overview
JLS was formed to invest at the healing edge of innovation across the brain tech and mental health ecosystem, including plant-based medicines, psychedelic-inspired neuroplastogens, and enabling tools and infrastructure . We focus on the development of drugs for intractable mental and physical conditions and the enhancement of wellness .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Immunis, Inc. | Jan 2025 | Series A Extension | Co-investor |
| Gilgamesh Pharmaceuticals | Dec 2022 | Series B | Co-investor |
| Enthea | Dec 2022 | Seed | Co-investor |
| Homecoming | Apr 2022 | Seed | Co-investor |
| Fluence | Feb 2022 | Seed | Lead |
Key People
Lindsay Hoover
Co-Founder, Managing Partner
Jeff Siegel
Managing Partner
Michael Gruber
Managing Partner
Simeon Schnapper
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
